Showing results (31-40 of 410) with videos related to
Sort By:
Pageof 41
Nature Reviews. Clinical Oncology|June 28, 2017
Monitoring immune-checkpoint blockade: response evaluation and biomarker developmentMizuki Nishino, Nikhil H Ramaiya, Hiroto Hatabu, et al.Journal for Immunotherapy of Cancer|November 21, 2014
Response assessment in metastatic melanoma treated with ipilimumab and bevacizumab: CT tumor size and density as markers for response and outcomeMizuki Nishino, Anita Giobbie-Hurder, Nikhil H Ramaiya, et al.Journal of Biological Methods|April 22, 2020
Standardized 11-color flow cytometry panel for the functional phenotyping of human T regulatory cellsClaire Manuszak, Martha Brainard, Emily Thrash, et al.Genes & Diseases|April 6, 2018
Unique Cytologic Features of Thyroiditis Caused by Immune Checkpoint Inhibitor Therapy for Malignant MelanomaTrevor E Angell, Le Min, Tad J Wieczorek, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 15, 2015
CCR 20th Anniversary Commentary: Immune-Related Response Criteria--Capturing Clinical Activity in Immuno-OncologyAxel Hoos, Jedd D Wolchok, Rachel W Humphrey, et al.Cancer Journal (Sudbury, Mass.)|August 8, 2014
Subverting the B7-H1/PD-1 pathway in advanced melanoma and kidney cancerLauren C Harshman, Toni K Choueiri, Charles Drake, et al.Frontiers in Oncology|May 30, 2024
Phase II trial of vaccination with autologous, irradiated melanoma cells engineered by adenoviral mediated gene transfer to secrete granulocyte-macrophage colony stimulating factor in patients with stage III and IV melanomaTamara A Sussman, Mariano Severgnini, Anita Giobbie-Hurder, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2013
Efficacy and safety of retreatment with ipilimumab in patients with pretreated advanced melanoma who progressed after initially achieving disease controlCaroline Robert, Dirk Schadendorf, Marianne Messina, et al.European Journal of Radiology|May 5, 2015
Cancer immunotherapy and immune-related response assessment: The role of radiologists in the new arena of cancer treatmentMizuki Nishino, Sree H Tirumani, Nikhil H Ramaiya, et al.AJR. American Journal of Roentgenology|July 26, 2011
Radiologic aspects of immune-related tumor response criteria and patterns of immune-related adverse events in patients undergoing ipilimumab therapyKevin N O'Regan, Jyothipriya P Jagannathan, Nikhil Ramaiya, et al.Pageof 41